9B5-60592-76567
3 vaccinations
6 coded responses
35 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 741 / OK
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Registered in v-safe
-
2021-02-27
Dose 1 — Pfizer-BioNTech
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-04
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-06
Health check-in — day 7, dose 1Feeling: Good · Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-13
-
2021-03-20
Dose 2 — Pfizer-BioNTech
-
2021-03-20
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-04-03
- 2021-04-12
- 2021-04-19
- 2021-04-25
- 2021-05-01
-
2021-06-19
Survey response — 3 months, dose 2MedDRA: Fatigue, Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Acute fatigue and migraines lasting more than 4 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-19
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling, Itching · Headache, Joint pains, Muscle or body aches, NauseaAdult check-in
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Headache, Joint painsFree text: swelling of axillary lymph nodesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
-
2021-10-31
Survey response — day 28, dose 3MedDRA: Fatigue, Headache, Nausea — Feeling: FairFree text: Consistent fatigue and nausea, headache like "fullness", unsure of originMedDRA releases: 2024-11 · check-in free text available
- 2021-11-07
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Immunodeficiency, Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Unsure if related, immunocompromised since time of booster. No changes in routine, diet, environment or cleanliness but experiencing URI's every few weeks, all with pretty high severityMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: Dizziness, Hypotension — Feeling: FairFree text: Hypotension, dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Survey response — 12 months, dose 3MedDRA: Brain fog, Fatigue, Palpitations, Tachycardia — Feeling: Poor · Be unable to work or attend schoolFree text: Cardiac sx such as palpitations, tachycardia, fatigue and brain fogMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Pfizer-BioNTech | |
| 2 | 2021-03-20 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
Free text
Release 9 — 3 months, dose 2
Symptoms: Acute fatigue and migraines lasting more than 4 hours
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): swelling of axillary lymph nodes
Release 10 — day 28, dose 3
Symptoms: Consistent fatigue and nausea, headache like "fullness", unsure of origin
Release 10 — 3 months, dose 3
Symptoms: Unsure if related, immunocompromised since time of booster. No changes in routine, diet, environment or cleanliness but experiencing URI's every few weeks, all with pretty high severity
Release 11 — 6 months, dose 3
Symptoms: Hypotension, dizziness
Release 12 — 12 months, dose 3
Symptoms: Cardiac sx such as palpitations, tachycardia, fatigue and brain fog
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypotension | · | · | ✓ |
| SD | Immunodeficiency | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release